December 22, 2010
Corcept Therapeutics Announces Positive Phase 3 Study Results for CORLUX for the Treatment of Cushing's Syndrome

December 21, 2010
Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate

December 16, 2010
Amarin Completes Patient Randomization in Phase 3 ANCHOR Trial

December 13, 2010
Panasonic to Manufacture PixelOptics' Electronic Focusing Eyeglass Lens Blanks

November 29, 2010
Amarin’s AMR101 Meets Pivotal Phase 3 Study Endpoints

November 19, 2010
Xanodyne Pharmaceuticals, Inc. To Voluntarily Withdraw Darvon® and Darvocet-N® Products

October 18, 2010
Solta Medical To Acquire CLRS Technology

October 11, 2010
Jazz Pharmaceuticals Receives FDA Complete Response Letter Regarding JZP-6 for Treatment of Fibromyalgia

October 5, 2010
Jazz Pharmaceuticals Announces Paragraph IV ANDA Filing for Xyrem

September 16, 2010
Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis

August 30, 2010
Aptus Endosystems Completes $15 Million Series AA Financing

August 20, 2010
Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting for JZP-6 (sodium oxybate) in Fibromyalgia

August 10, 2010
Amarin’s AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization

August 6, 2010
Aptus Endosystems Completes First EndoStapling Procedures in Europe

July 1, 2010
Corcept Therapeutics Completes Enrollment in Phase 3 Cushing's Syndrome Study - Data Announcement Anticipated by Year End

June 30, 2010
Jazz Pharmaceuticals Announces Completion of Refinancing of its 15% Senior Secured Notes Due June 2011 with Closing of $50 Million Term Loan Due June 2013

June 30, 2010
Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts

June 29, 2010
AqueSys, Inc. Closes $35 Million Series C Round Led by Longitude Capital and Rho Ventures

June 25, 2010
Corcept Therapeutics Announces Pricing of $15 Million Underwritten Offering of Common Stock

June 17, 2010
$35 Million Investment Raised by Precision Therapeutics

May 11, 2010
Jazz Pharmaceuticals Announces Pricing of Public Offering of Common Stock

May 7, 2010
Xanodyne Announces Renewed Focus on Pain Management Market

May 3, 2010
Corcept Therapeutics Updates Cushing's Syndrome Development and Recent Financing

April 22, 2010
Corcept Therapeutics Announces Exercise of Existing Warrants and Private Placement of Warrants

April 1, 2010
Xanodyne and Ferring Announce Co-Promote for Zipsor

March 23, 2010
Corcept Therapeutics Initiates a Phase 1 Study of CORT 108297

March 19, 2010
PixelOptics Unveils Bold Marketplace Approach for Electronic Eyewear

February 23, 2010
Solta Medical to Acquire Aesthera Corporation

February 18, 2010
Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia

January 11, 2010
Amarin Announces First Patients Enrolled in Two Phase 3 Clinical Trials for AMR101

January 8, 2010
Solta Medical to Raise $17.2 Million in Private Placement

January 5, 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010

January 5, 2010
Panasonic Shikoku Electronics Joins PixelOptics in Development of Electronic Eye Glasses


© 2008 Longitude Capital Management Co., LLC. All rights reserved.